North America HLA typing transplant diagnostics services is expected to register a healthy CAGR in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

The major factors contributing to the growth of the market includes factors such as technological advancements in HLA typing, increasing number of solid organ and stem cell transplantation procedures and increased research grants, funds, and public-private investments.

The key market players for North America HLA typing transplant diagnostics services are listed below;

Thermo Fisher Scientific Inc.
Proimmune ltd.
Laboratory Corporation Of America Holdings
Creative Biolabs and
Histogenetics LLC
THE UCLA immunogenetics center.
Admera Health
Quick Biology
NEW YORK blood center
The Sequencing Center
Bloodcenter of Wisconsin
Thermo Fisher Scientific Inc.

The market is further segmented into;
Technology
Technique
End-Users

The North America HLA typing transplant diagnostics services market is segmented on the basis of technology into polymerase chain reaction (PCR) and next-generation sequencing (NGS). In 2018, Polymerase Chain Reaction (PCR) is expected to dominate the hospital LIMS market with 52.0% market share growing at a CAGR of 8.6% in the forecast period 2018 to 2025. However, next-generation sequencing (NGS) segment is expected to grow at the highest CAGR in the forecast period.
The North America HLA typing transplant diagnostics services market is segmented on the basis of technique into PCR-SSP (Sequence-Specific Primer), PCR SSOP (Sequence-Specific Oligonucleotide) and PCR-SBT (Sequencing Based Typing). In 2018, PCR-SSP (Sequence-Specific Primer) is expected to dominate the market with highest market share and is growing at a healthy CAGR in the forecast period 2018 to 2025. However, PCR-SBT (Sequencing Based Typing) market segment is expected to grow at the highest CAGR in the forecast period.
The North America HLA typing transplant diagnostics services market is segmented on the basis of end-users into hospitals, transplant centers, specialty clinics and academic institutes. In 2018, on-premise hospital LIMS is expected to dominate the hospital LIMS market in the forecast period 2018 to 2025. However, hospitals market segment is expected to grow at the highest CAGR and is expected to reach USD 185.24 million in 2025.
Based on geography, the market is segmented into 3 geographical regions;
U.S.
Canada
Mexico
Covered in this report
The report covers the present scenario and the growth prospects of the North America HLA typing transplant diagnostics services for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.